Bluejay Diagnostics
BJDX
4 hedge funds and large institutions have $243K invested in Bluejay Diagnostics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
144% more capital invested
Capital invested by funds: $99.8K → $243K (+$144K)
100% more funds holding
Funds holding: 2 → 4 (+2)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$439K |
| 2 |
AC
Armistice Capital
New York
|
+$81.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$75.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$674 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $183K | +$439K | +81 | +623% |
|
|
AC
2
Armistice Capital
New York
| $29.6K | +$81.3K | +15 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $26.8K | +$75.9K | +14 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.97K | +$5.42K | +1 | +100% |
|
5
JP Morgan Chase
New York
| $74 | – | – | – |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $30 | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $7 | – | – | – |
|
|
CAS
8
Coppell Advisory Solutions
Coppell,
Texas
| – | -$674 | – | – |
|
BJDX Hedge Fund Activity: Q4 2023 in Review
4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q4 2023, worth a combined $243K — up 144% from $99.8K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BJDX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $439K. The largest seller was Coppell Advisory Solutions, cutting an estimated $674.
- 4 institutional investors held Bluejay Diagnostics (BJDX) as of Q4 2023, up from 2 in Q3 2023.
- Funds reported $243K of Bluejay Diagnostics stock for Q4 2023, up 144% quarter-over-quarter.
- 2 funds opened new Bluejay Diagnostics positions in Q4 2023 and 0 closed out, a net change of +2 holders.
- The largest Bluejay Diagnostics buyer in Q4 2023 was Sabby Management, an estimated $439K added.
- The largest Bluejay Diagnostics seller in Q4 2023 was Coppell Advisory Solutions, an estimated $674 sold.
Based on aggregated 13F filings for Q4 2023.